Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine versus melatonin for ECT-related memory impairment
IRCT20121021011192N8Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of memantine and melatonin in cognitive disorder (CD) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: MMSE questionnaire score. Started Aug 2018; status: completed.
02
Drugs
memantinemelatonin
03
Conditions
cognitive disorder (CD)
Beyond the preview
Go deeper on IRCT20121021011192N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121021011192N8.